|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,031.00 GBX | 0.00% |
|
-0.34% | +11.32% |
| 14/03 | GSK and Amgen to add medicines to TrumpRx, Fox Business reports | RE |
| 13/03 | GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 12.75x | 4.33x | 0.99x | 2.76x | 7.99x | 9.17x | 3.41% | 11TCr | ||
| 28.95x | 17.84x | 0.6x | 10.91x | 21.91x | 23.33x | 0.67% | 88TCr | ||
| 25.63x | 6.65x | -1.76x | 5.96x | 16.23x | 17.93x | 2.19% | 58TCr | ||
| 24x | 59.07x | 0.08x | 6.55x | 13.15x | 13.49x | 3.16% | 39TCr | ||
| 17.32x | 6.15x | 1.12x | 4.22x | 10.43x | 11.82x | 3.13% | 32TCr | ||
| 23.94x | 5.42x | 1.11x | 4.99x | 13.83x | 14.84x | 1.75% | 30TCr | ||
| 20.93x | 6.19x | 11.48x | 5.64x | 13.96x | 14.93x | 2.87% | 29TCr | ||
| 27.02x | 5.05x | -0.66x | 4.74x | 14.82x | 17.51x | 2.92% | 29TCr | ||
| 24.64x | 16.55x | 5.52x | 6.26x | 11.14x | 14.22x | 2.74% | 20TCr | ||
| 20.1x | 6.81x | 3.14x | 6.12x | 11.06x | 13.02x | 2.25% | 18TCr | ||
| 11.62x | 5x | -1.51x | 4.21x | 8.75x | 10.2x | 4.33% | 17TCr | ||
| 12.44x | 1.66x | 0.22x | 3.16x | 7.54x | 8.91x | 6.61% | 15TCr | ||
| 26.77x | 5.26x | 1.85x | 8.12x | 18.13x | 18.83x | -.--% | 12TCr | ||
| 11.81x | 5.16x | 0.27x | 3.11x | 8.38x | 9x | 4.26% | 12TCr | ||
| 12.03x | 1.18x | -15.65x | 2.21x | 7.26x | 7.89x | 5.54% | 11TCr | ||
| 36x | 7.78x | 3.43x | 11.64x | 22.87x | 24.38x | 2.71% | 9.65TCr | ||
| 50.74x | 1.29x | 0.8x | 2.84x | 10.52x | 29.92x | 3.53% | 5.61TCr | ||
| 42.39x | 6x | 1.41x | 9.89x | 33.45x | 34.79x | 0.48% | 5.3TCr | ||
| 21.28x | 2.03x | 1.75x | 3.7x | 14.62x | 16.36x | 1.89% | 4.42TCr | ||
| 31.27x | 1.33x | -0.23x | 1.55x | 7.44x | 12.53x | 0.59% | 4.34TCr | ||
| Average | 24.08x | 8.54x | 0.70x | 5.43x | 13.68x | 16.15x | 2.75% | 22.46TCr | |
| Weighted average by Cap. | 23.75x | 12.93x | 0.90x | 6.43x | 14.87x | 16.54x | 2.46% |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















